Citations

Showing 10 of 108094 citations.

Knowledge of venomous snakes, snakebite first aid, treatment, and prevention among clinicians in northern Nigeria: a cross-sectional multicentre study
Michael, Godpower Chinedu , Grema, Bukar Alhaji , Aliyu, Ibrahim , Alhaji, Mohammed Arab , Lawal, Teslim O, Ibrahim, Haliru, Fikin, Aminu G, Gyaran, Fatima S, Kane, Kennedy N, Thacher, Thomas D, Badamasi, Abba K, Ogwuche, Emmanuel, Thacher, Tom D. , Thacher, Thomas D

Mayo Clinic

Transactions of The Royal Society of Tropical Medicine and Hygiene | March 2, 2018 | Volume: 112 | Issue: 2 | Pages: 47-56

10.1093/trstmh/try028 | PMID 29617989 Get It

A practical approach to the diagnosis of spinal cord lesions
Mariano, Romina , Weinshenker, Brain G, Palace, Jacqueline , Palace, Jacqueline , Flanagan, Eoin P. , Weinshenker, Brian G. , Palace, Jacqueline

Mayo Clinic

Practical Neurology | March 2, 2018 | Volume: 18 | Issue: 3 | Pages: 187-200

10.1136/practneurol-2017-001845 | PMID 29500319 Get It

Every neurologist will be familiar with the patient with atypical spinal cord disease and the challenges of taking the diagnosis forward. This is predominantly because of the limited range of possible clinical and investigation findings making most individual features non-specific. The difficulty in obtaining a tissue diagnosis further contributes and patients are often treated empirically based on local prevalence and potential for reversibility. This article focuses on improving the diagnosis of adult non-traumatic, non-compressive spinal cord disorders. It is structured to start with the clinical presentation in order to be of practical use to the clinician. We aim, by combining the onset phenotype with the subsequent course, along with imaging and laboratory features, to improve the diagnostic process.
Therapeutic Approach to Patients with Heart Failure with Reduced Ejection Fraction and End-stage Renal Disease
Inampudi, Chakradhari , Álvarez, Paulino , Briasoulis, Αlexandros , Asleh, Rabea , Briasoulis, Alexandros

Mayo Clinic

Current Cardiology Reviews | March 2, 2018 | Volume: 14 | Issue: 1 | Pages: 60-66

10.2174/1573403x14666180123164916 | PMID 29366423 Get It

A Retrospective Estimate of Ear Disease Detection Using the “Red Flags” in a Clinical Sample
Klyn, Niall A. M. , Alfakir, Razan , Nielsen, Donald W., Carlson, Deborah , Lundy, Larry, Dhar, Sumitrajit , Zapala, David A., Kleindienst Robler, Samantha, Alfakir, Razan , Robler, Samantha Kleindienst , Griffith, James William

Mayo Clinic

Ear & Hearing | March 2, 2018 | Volume: 39 | Issue: 5 | Pages: 1035-1038

10.1097/aud.0000000000000561 | PMID 29498954 Get It

Objectives: The purpose of this study was to evaluate the specificity and sensitivity of two red flag protocols in detecting ear diseases associated with changes in hearing. Design: The presence of red-flag symptoms was determined in a chart review of 307 adult patients from the Mayo Clinic Florida Departments of Otorhinolaryngology and Audiology. Participants formed a convenience sample recruited for a separate study. Neurotologist diagnosis was the criterion for comparisons. Results: Of the 251 patient files retained for analysis, 191 had one or more targeted diseases and 60 had age- or noise-related hearing loss. Food and Drug Administration red flags sensitivity was 91% (confidence interval [CI], 86 to 95%) and specificity was 72% (CI, 59 to 83%). American Academy of Otolaryngology-Head and Neck Surgery red flags sensitivity was 98% (CI, 95 to 99%) and specificity was 20% (CI, 11 to 32%). Conclusions: Stakeholders must determine which diseases are meaningful contraindications for hearing aid use and whether these red-flag protocols have acceptable levels of sensitivity and specificity. As direct-to-consumer models of hearing devices increase, a disease detection method that does not require provider intercession would be useful.
Increased Body Mass Index Associated With Reduced Risk of Delayed Cerebral Ischemia and Subsequent Infarction After Aneurysmal Subarachnoid Hemorrhage
Rinaldo, Lorenzo , Rabinstein, Alejandro A. , Lanzino, Giuseppe

Mayo Clinic

Neurosurgery | March 2, 2018 | Volume: 84 | Issue: 5 | Pages: 1035-1042

10.1093/neuros/nyy104 | PMID 29659999 Get It

Abstract BACKGROUND Increased body mass index (BMI) may be protective against cerebral ischemia in certain clinical contexts. OBJECTIVE To investigate whether increased BMI was associated with delayed cerebral ischemia (DCI) and subsequent infarction after aneurysmal subarachnoid hemorrhage (aSAH). METHODS We retrospectively reviewed the clinical course of patients presenting to our institution for management of aSAH. Patient were segregated according to BMI< or ≥29.4, a value determined by Classification and Regression Tree analysis. Predictors of DCI and delayed infarction were identified using stepwise multivariate logistic regression analysis. RESULTS There were 161 patients included for analysis. Average BMI within our patient cohort was 28.9, with 67 patients presenting with a BMI of ≥29.4 on admission. DCI occurred in 50 patients (31.1%) and was complicated by delayed infarction in 15 patients (9.3%). On stepwise multivariate analysis, BMI ≥ 29.4 was independently associated with reduced likelihood of DCI (odds ratio [OR] 0.42, 95% confidence interval [CI] 0.18-0.92) and delayed infarction (OR 0.13, 95% CI 0.02-0.61; P = .008). Increasing maximum flow velocity on transcranial Doppler ultrasound was independently associated with increased odds of both DCI (Unit OR 1.19, 95% CI 1.09-1.30; P < .001) and delayed infarction (Unit OR 1.31, 95% CI 1.13-1.56; P < .001), while intracerebral hemorrhage was independently associated with increased odds of delayed infarction (OR 6.99, 95% CI 1.82-30.25; P = .005). CONCLUSION We report an association between elevated BMI and reduced incidence of DCI and delayed infarction, suggesting a protective effect of increasing BMI on the risk of ischemic complications after aSAH.
Impact of Supplemental Oxygen on Obstructive Sleep Apnea of Infants
Das, Piyush , Kashyap, Rahul , Kotagal, Suresh , Kashyap, Rahul

Mayo Clinic

Children | March 2, 2018 | Volume: 5 | Issue: 3 | Pages: 34

10.3390/children5030034 | PMID 29498675 Get It

Treatment options may be limited for infants with obstructive sleep apnea when there is no surgically correctable upper airway lesion. We therefore evaluated, retrospectively, the efficacy of low-flow oxygen as a therapeutic option for infant obstructive sleep apnea. We reviewed the medical charts of 23 infants who had undergone a therapeutic trial of low-flow oxygen during polysomnography. Split-night polysomnography was used in 21/23 subjects while 2/23 had undergone two separate, full-night polysomnography sleep architecture and respiratory findings on the baseline polysomnogram segment that was obtained in room air were compared with the segment on low-flow oxygen (0.25–1 L/min). Wilcoxon signed rank or McNemar’s test were used as indicated for comparing apnea hypopnea index and measures of sleep architecture at baseline and with oxygen therapy. The mean (±SD) age of subjects was 4.8 (±2.7) months, with 52% being males. The median apnea hypopnea index fell from a baseline of 18 (range 7–43) to 3 (range 1–19; p = 0.001) on oxygen. The baseline median obstructive/mixed apnea index decreased from 2 (range 1–16) to 1 during oxygen therapy (range 0–1; p = 0.003). Additionally, a significant decrease in central apnea index (median interquartile range (IQR) 1 (0–2) vs. 0 (0–1), p = 0.002) was noted. Sleep efficiency remained unaffected, while O2 saturation (SaO2) average and SaO2 nadir improved on oxygen. We were able to confirm the utility of low-flow oxygen in reducing central, obstructive, and mixed apneas and improving average oxygen saturation in infants with obstructive sleep apnea (OSA).
Impact of preoperativeBRCA1/2testing on surgical decision making in patients with newly diagnosed breast cancer
Yadav, Siddhartha , Jinna, Sruthi , Pereira-Rodrigues, Otavio, Reeves, Ashley , Campian, Sarah, Sufka, Amy, Zakalik, Dana , Yadav, Siddhartha

Mayo Clinic

The Breast Journal | March 2, 2018 | Volume: 24 | Issue: 4 | Pages: 541-548

10.1111/tbj.13007 | PMID 29498445 Get It

Normal values for assessment of anal sphincter morphology, anorectal motion, and pelvic organ prolapse with MRI in healthy women
Tirumanisetty, Pratyusha , Prichard, David O. , Zinsmeister, Alan R., Bharucha, Adil E. , Bharucha, A E , Fletcher, Joel G. , Chakraborty, Sumit

Mayo Clinic

Neurogastroenterology & Motility | March 2, 2018 | Volume: 30 | Issue: 7 | Pages: No page available

10.1111/nmo.13314 | PMID 29498141 Get It

AbstractBackgroundEndoanal MRI and MR defecography are used to identify anal sphincter injury and disordered defecation. However, few studies have evaluated findings in asymptomatic healthy people. The effects of BMI and parity on rectoanal motion and evacuation are unknown.MethodsIn 113 asymptomatic females (age 50 ± 17 years, Mean ± SD) without risk factors for anorectal trauma, anal sphincter appearance, anorectal motion, and pelvic organ prolapse were evaluated with MRI. The relationship between age, BMI, and parity and structural findings were evaluated with parametric and non‐parametric tests.ResultsThe anal sphincters and puborectalis appeared normal in over 90% of women. During dynamic MRI, the anorectal angle was 100 ± 1º (Mean ± SEM) at rest, 70 ± 2° at squeeze, and 120 ± 2° during defecation. The change in anorectal angle during squeeze (r = −.25, P < .005), but not during evacuation (r = .13, P = .25) was associated with age. In the multivariable models, BMI (P < .01) and parity (P < .01) were, respectively, independently associated with the intersubject variation in the anorectal angle at rest and the angle change during squeeze. Ten percent or fewer women had had descent of the bladder base or uterus 4 cm or more below the pubococcygeal line or a rectocele measuring 4 cm or larger. Only 5% had a patulous anal canal.ConclusionsIn addition to age, BMI and parity also affect anorectal motion in asymptomatic women. These findings provide age‐adjusted normal values for rectoanal anatomy and pelvic floor motion.
Noninvasive Ventilation in Patients With Do-Not-Intubate and Comfort-Measures-Only Orders: A Systematic Review and Meta-Analysis*
Wilson, Michael E. , Majzoub, Abdul M., Dobler, Claudia C. , Curtis, J. Randall , Nayfeh, Tarek , Barwise, Amelia , Tilburt, Jon C. , Murad, M. Hassan , Thorsteinsdottir, Bjorg , Barwise, Amelia K, Murad, M Hassan , Barwise, Amelia K , Gajic, Ognjen , Montori, Víctor M. , Nayfeh, Tarek

Mayo Clinic

Critical Care Medicine | March 2, 2018 | Volume: 46 | Issue: 8 | Pages: 1209-1216

10.1097/ccm.0000000000003082 | PMID 29498939 Get It

Objectives: To assess the effectiveness of noninvasive ventilation in patients with acute respiratory failure and do-not-intubate or comfort-measures-only orders. Data Sources: MEDLINE, EMBASE, CINAHL, Scopus, and Web of Science from inception to January 1, 2017. Study Selection: Studies of all design types that enrolled patients in the ICU or hospital ward who received noninvasive ventilation and had preset do-not-intubate or comfort-measures-only orders. Data Extraction: Data abstraction followed Meta-analysis of Observational Studies in Epidemiology guidelines. Data quality was assessed using a modified Newcastle-Ottawa Scale. Data Synthesis: Twenty-seven studies evaluating 2,020 patients with do-not-intubate orders and three studies evaluating 200 patients with comfort-measures-only orders were included. In patients with do-not-intubate orders, the pooled survival was 56% (95% CI, 49–64%) at hospital discharge and 32% (95% CI, 21–45%) at 1 year. Hospital survival was 68% for chronic obstructive pulmonary disease, 68% for pulmonary edema, 41% for pneumonia, and 37% for patients with malignancy. Survival was comparable for patients treated in a hospital ward versus an ICU. Quality of life of survivors was not reduced compared with baseline, although few studies evaluated this. No studies evaluated quality of dying in nonsurvivors. In patients with comfort-measures-only orders, a single study showed that noninvasive ventilation was associated with mild reductions in dyspnea and opioid requirements. Conclusions: A large proportion of patients with do-not-intubate orders who received noninvasive ventilation survived to hospital discharge and at 1 year, with limited data showing no decrease in quality of life in survivors. Provision of noninvasive ventilation in a well-equipped hospital ward may be a viable alternative to the ICU for selected patients. Crucial questions regarding quality of life in survivors, quality of death in nonsurvivors, and the impact of noninvasive ventilation in patients with comfort-measures-only orders remain largely unanswered.
Pulmonary embolism attenuation is a potential imaging biomarker for pulmonary artery hemodynamic improvement after catheter-directed thrombolysis
Takahashi, Edwin A. , Reisenauer, Christopher J., Stockland, Andrew H., Bjarnason, Haraldur , Neisen, Melissa , Neidert, Newton B. , Harmsen, William S. , Day, Courtney N. , Misra, Sanjay , Neisen, Melissa J, Misra, Sanjay , Takahashi, Edwin A , Bjarnason, Haraldur

Mayo Clinic

Vascular Medicine | March 2, 2018 | Volume: 23 | Issue: 2 | Pages: 134-138

10.1177/1358863x18756504 | PMID 29498612 Get It

This study examined the potential correlation between pulmonary embolism (PE) attenuation on computed tomography pulmonary angiography (CTPA) and pulmonary artery hemodynamic response to catheter-directed thrombolysis (CDT) in 10 patients with submassive PE. Treatment parameters, PE attenuation, clot burden, computed tomography signs of right ventricle dysfunction and right ventricular systolic pressure at echocardiography were retrospectively analyzed to determine correlation with pulmonary artery pressure improvement using Spearman correlation. A single reader, blinded to the treatment results, measured PE attenuation of all patients. There was a significant positive correlation between PE attenuation and absolute pulmonary artery pressure improvement with a Spearman correlation of 0.741, p=0.014. When attenuation was greater than or equal to the median (44.5 HU, n=5), CDT was associated with significantly better pulmonary artery pressure improvement ( p=0.037). Clot attenuation at CTPA may be a potential imaging biomarker for predicting pulmonary artery pressure improvement after CDT.